Distinctions between fraud, bias, errors, misunderstanding, and incompetence

被引:11
作者
DeMets, DL
机构
来源
CONTROLLED CLINICAL TRIALS | 1997年 / 18卷 / 06期
关键词
randomized clinical trial; bias; error; misunderstanding; incompetence; fraud;
D O I
10.1016/S0197-2456(97)00010-X
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Randomized clinical trials are challenging not only in their design and analysis, but in their conduct as well. Despite the best intentions and efforts, problems often arise in the conduct of trials, including errors, misunderstandings, and bias. In some instances, key players in a trial may discover that they are not able or competent to meet requirements of the study. In a few cases, fraudulent activity occurs. While none of these problems is desirable, randomized clinical trials are usually found sufficiently robust by many key individuals to produce valid results. Other problems are not tolerable. Confusion may arise among scientists, scientific and lay press, and the public about the distinctions between these areas and their implications. We shall try to define these problems and illustrate their impact through a series of examples. (C) Elsevier Science Inc. 1997.
引用
收藏
页码:637 / 650
页数:14
相关论文
共 23 条
[1]   SETTING THE RECORD STRAIGHT IN THE BREAST-CANCER TRIALS [J].
ANGELL, M ;
KASSIRER, JP .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (20) :1448-1450
[2]  
Anturane Reinfarction Trial Research Group, 1978, NEW ENGL J MED, V298 , P289
[3]   DETECTING FABRICATION OF DATA IN A MULTICENTER COLLABORATIVE ANIMAL STUDY [J].
BAILEY, KR .
CONTROLLED CLINICAL TRIALS, 1991, 12 (06) :741-752
[4]   DATA INTEGRITY [J].
DEMETS, DL ;
MEINERT, CL .
CONTROLLED CLINICAL TRIALS, 1991, 12 (06) :727-730
[5]   A RANDOMIZED CLINICAL-TRIAL EVALUATING SEQUENTIAL METHOTREXATE AND FLUOROURACIL IN THE TREATMENT OF PATIENTS WITH NODE-NEGATIVE BREAST-CANCER WHO HAVE ESTROGEN-RECEPTOR-NEGATIVE TUMORS [J].
FISHER, B ;
REDMOND, C ;
DIMITROV, NV ;
BOWMAN, D ;
LEGAULTPOISSON, S ;
WICKERHAM, DL ;
WOLMARK, N ;
FISHER, ER ;
MARGOLESE, R ;
SUTHERLAND, C ;
GLASS, A ;
FOSTER, R ;
CAPLAN, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (08) :473-478
[6]   A RANDOMIZED CLINICAL-TRIAL EVALUATING TAMOXIFEN IN THE TREATMENT OF PATIENTS WITH NODE-NEGATIVE BREAST-CANCER WHO HAVE ESTROGEN-RECEPTOR POSITIVE TUMORS [J].
FISHER, B ;
COSTANTINO, J ;
REDMOND, C ;
POISSON, R ;
BOWMAN, D ;
COUTURE, J ;
DIMITROV, NV ;
WOLMARK, N ;
WICKERHAM, DL ;
FISHER, ER ;
MARGOLESE, R ;
ROBIDOUX, A ;
SHIBATA, H ;
TERZ, J ;
PATERSON, AHG ;
FELDMAN, MI ;
FARRAR, W ;
EVANS, J ;
LICKLEY, HL ;
KETNER, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (08) :479-484
[7]  
FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707
[8]  
Friedman LM, 1985, FUNDAMENTALS CLIN TR
[9]   DOUBLE-BLIND STUDY OF EFFECTS OF ZINC-SULFATE ON TASTE AND SMELL DYSFUNCTION [J].
HENKIN, RI ;
SCHECTER, PJ ;
FRIEDEWALD, WT ;
DEMETS, DL ;
RAFF, M .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1976, 272 (03) :285-299
[10]   ASCORBIC-ACID FOR COMMON COLD - PROPHYLACTIC AND THERAPEUTIC TRIAL [J].
KARLOWSKI, TR ;
CHALMERS, TC ;
FRENKEL, LD ;
KAPIKIAN, AZ ;
LEWIS, TL ;
LYNCH, JM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1975, 231 (10) :1038-1042